Givaudan SA
DUS:GIN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Givaudan SA
DUS:GIN
|
CH |
|
Emergent BioSolutions Inc
NYSE:EBS
|
US |
|
Domino's Pizza Inc
NASDAQ:DPZ
|
US |
|
Doximity Inc
NYSE:DOCS
|
US |
|
London Stock Exchange Group PLC
F:LS4D
|
UK |
|
U
|
Unipres Corp
TSE:5949
|
JP |
Wall St Price Targets
GIN Price Targets Summary
Givaudan SA
According to Wall Street analysts, the average 1-year price target for GIN is 3 519.58 EUR with a low forecast of 1 269.58 EUR and a high forecast of 4 411.18 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIN's stock price target?
Price Target
3 519.58
EUR
According to Wall Street analysts, the average 1-year price target for GIN is 3 519.58 EUR with a low forecast of 1 269.58 EUR and a high forecast of 4 411.18 EUR.
What is the Revenue forecast for Givaudan SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Givaudan SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 5 years is 5%.
What is the Operating Income forecast for Givaudan SA?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Givaudan SA?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Givaudan SA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 5 years is 7%.
